Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/7845
Serological Cytokine and chemokine profile in pregnant women with COVID19 in Mexico City | |
BERENICE ZAVALA BARRIOS JESÚS CARLOS BRIONES GARDUÑO GUADALUPE M.L. GUERRERO AVENDAÑO Eduardo Ferat Patricia Miranda Cruz Arturo Cérbulo-Vázquez Lourdes Arriaga_Pizano MARIA TERESA GARCIA DE LA ROSA Jessica Lakshmi Prieto-Chávez Vanessa Rivero-Arredondo RUTH MADERA ENRIQUE SALAZAR RÍOS Roberto Carlos De Lira Barraza Abel Humberto Villanueva Compean CONSTANTINO LOPEZ MACIAS guillermo flores padilla | |
Acceso Abierto | |
Atribución-SinDerivadas | |
https://doi.org/10.1101/2020.07.14.20153585 | |
On January 30th, 2020, the WHO declared the outbreak of COVID19, a disease due to the new coronavirus called SARS-CoV-2. Certain comorbidities, symptoms and signs are characteristic of COVID19 in the general population and in pregnant women. However, pregnant women are considered as a high-risk group for COVID19. To know about the frequency of comorbidities, signs and symptoms, the presence of lymphopenia, antibodies response to SARS-CoV2 and cytokine and chemokine serum concentration, six pregnant women with COVID19 were studied at the moment of admission. The lower concentration of CCL17 was detected in the Pregnant COVID19 group, similar concentration of IL-6 was also detected in non-pregnant and pregnant COVID19 patients. Our result show that pregnant and non-pregnant women with COVID19 has similar cytokine profile. | |
Medrxiv | |
17-07-2020 | |
Preimpreso | |
medrxiv.org/ | |
Inglés | |
VIRUS RESPIRATORIOS | |
Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
Fichero | Tamaño | Formato | |
---|---|---|---|
Serological Cytokine and chemokine profile in pregnant women with COVID19 in Mexico City.pdf | 144.79 kB | Adobe PDF | Visualizar/Abrir |